Do All Patients with Multiple Sclerosis Benefit from the Use of Contrast on Serial Follow-Up MR Imaging? A Retrospective Analysis [ADULT BRAIN]
CONCLUSIONS:
Because all enhancing lesions were associated with new lesions on unenhanced imaging and progression was only evident in 24% of patients, in patients with relapsing-remitting MS, it is reasonable to consider reserving contrast for only those patients with evidence of progression on noncontrast MR images.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Mattay, R. R., Davtyan, K., Bilello, M., Mamourian, A. C. Tags: ADULT BRAIN Source Type: research